0001171843-19-000065.txt : 20190103 0001171843-19-000065.hdr.sgml : 20190103 20190103081959 ACCESSION NUMBER: 0001171843-19-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190103 DATE AS OF CHANGE: 20190103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kowalsky Matthew Paul CENTRAL INDEX KEY: 0001705824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 19503680 MAIL ADDRESS: STREET 1: 28 SEVINOR RD CITY: MARBLEHEAD STATE: MA ZIP: 01945 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml X0306 4 2018-12-31 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001705824 Kowalsky Matthew Paul C/O PROTEON THERAPEUTICS, INC. 200 WEST STREET WALTHAM MA 02451 0 1 0 0 VP, Legal and Secretary Common Stock 2018-12-31 5 A 0 E 2448 1.93 A 29479 D The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of July 1, 2018 through December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). /s/ George A. Eldridge, attorney-in-fact 2019-01-03